Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510094 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Treatment for Relational Aggression in Urban African American Girls
A Phase 3 study of Aggression, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT00510094: Completed Phase 3 study of Aggression, sponsored by Children's Hospital of Philadelphia.
NCT00510094 is a Phase 3 study of Aggression that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 144 participants, roughly in line with the 148-participant average among 21 other Aggression trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00510094, a Phase 3 study of Aggression, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a school-based social cognitive group treatment in reducing aggression (bullying) among relationally aggressive urban African American girls.
Conditions Studied
Interventions
- BEHAVIORAL Friend to Friend program
- BEHAVIORAL Psychoeducational attention control intervention
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2007-10 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
What the finished NCT00510094 record still lists
NCT00510094 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 148-participant average among 21 other Aggression trials with a reported enrollment target.
The record links to 1 condition, with Aggression appearing as the primary indexed condition, and to 2 interventions - of which Friend to Friend program is the first listed.
NCT00510094 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00510094 about?
NCT00510094 is a clinical study titled "Effectiveness of Treatment for Relational Aggression in Urban African American Girls". This study will evaluate the effectiveness of a school-based social cognitive group treatment in reducing aggression (bullying) among relationally aggressive urban African American girls.
What is the current status of trial NCT00510094?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2007-10. Estimated completion is 2015-05.
What conditions does trial NCT00510094 study?
This clinical trial studies the following conditions: Aggression.
What interventions are being tested in trial NCT00510094?
The interventions under investigation include: Friend to Friend program (BEHAVIORAL), Psychoeducational attention control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00510094?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00510094 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00510094's enrollment target sits among peer trials
144 9th of 21 higher than 13 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
RECRUITING · Phase 2
-
Clinical Trial on Agitation in Alzheimer's Dementia
RECRUITING · Phase 2
-
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia